Shanshan Xu Founder of Bambusa Therapeutics Backed byBiotechnology Value FundJanus Henderson InvestorsRA Capital ManagementBeau BokelmanMark Nathan LampertRichard Aldrich LinkedIn SourcesBambusa Therapeutics Raises Approximately $90 Million in Series A Financing to Advance Next-generation Bispecific Antibodies for Immunology & Inflammation Diseases — 2025-02 Browse all founders · Browse investors
